Ledger.Open graph →

SEC Form D · filed June 20, 2018

BRAINSTORM CELL THERAPEUTICS INC

Offering

—

Sold

—

Exemption

Rule 506(b)

Industry

Biotechnology

Location

NEW YORK, NY

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Dr. Anthony Polverino · NEW YORK, NYDirector Uri Yablonka · NEW YORK, NYExec · Director Chaim Lebovits · NEW YORK, NYExec Ralph Kern · NEW YORK, NYExec Dr. June Almenoff · NEW YORK, NYDirector Dr. Irit Arbel · NEW YORK, NYDirector Arturo Araya · NEW YORK, NYDirector Eyal Rubin · NEW YORK, NYExec Chen Schor · Westminster, CODirector Malcolm Taub · NEW YORK, NYDirector Dr. Anthony Polverino · NEW YORK, NYDirector Uri Yablonka · NEW YORK, NYExec · Director Chaim Lebovits · NEW YORK, NYExec Ralph Kern · NEW YORK, NYExec Dr. June Almenoff · NEW YORK, NYDirector Dr. Irit Arbel · NEW YORK, NYDirector Arturo Araya · NEW YORK, NYDirector Eyal Rubin · NEW YORK, NYExec Chen Schor · Hackensack, NJDirector Malcolm Taub · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗